Clinical Drug Experience Knowledgebase

15-valent pneumococcal conjugate vaccine (2 trials)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

bacille calmette-guerin (4 trials)

esat6-cfp10 (6 trials)

men-acyw135 (2 trials)

meningococcal a&c vaccine (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

rabies vaccine (1 trial)

rabies vaccine, human isolate (1 trial)

recombinant new coronavirus vaccine (cho cell) (8 trials)

recombinant new coronavirus vaccine (cho cells) (4 trials)

s.flexneriza-s.sonnei bivalent conjugate vaccine (3 trials)

tetravalent influenza virus lysis vaccine (1 trial)

vaccae (1 trial)

coronavirus vaccine (4 trials)

haemophilus influenzae type b conjugate vaccine (PedvaxHIB) (1 trial)

menabc (1 trial)

menac (1 trial)

renov gi.1-vp1 (1 trial)

Tuberculin, Purified Protein Derivative (Tubersol) (2 trials)

aec / bc02 (1 trial)

menacwy conjugate vaccine (1 trial)

mycobacterium tuberculosis antigen (1 trial)

inactivated covid-19 vaccine (1 trial)

omicron covid-19 vaccine (vero cell), inactivated (1 trial)